← all signals · sectors · research

BIOMERICA INC BMRA

SIC 2835 — In Vitro & In Vivo Diagnostic Substances · CIK 73290

This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).

FY2024 short

1 signal fired · match: singles_avg

dso_drift_severe

HorizonPredicted net PnL
20 days-2.54%
60 days-11.34%
252 days (1y)-24.65%

FY2023 short

2 signals fired · match: pair

dso_drift_severe, margin_compression_severe

HorizonPredicted net PnL
20 days+1.59%
60 days-24.76%
252 days (1y)-56.45%

FY2021 short

1 signal fired · match: singles_avg

margin_compression_severe

HorizonPredicted net PnL
20 days-4.81%
60 days-75.14%
252 days (1y)-31.94%

FY2019 short

2 signals fired · match: pair

dso_drift_severe, margin_compression_severe

HorizonPredicted net PnL
20 days+1.59%
60 days-24.76%
252 days (1y)-56.45%

FY2014 short

3 signals fired · match: triple

dso_drift_severe, fcf_turn_negative, profit_to_loss

HorizonPredicted net PnL
20 days+0.78%
60 days-4.21%
252 days (1y)-9.86%

FY2013 long

1 signal fired · match: singles_avg

fcf_turn_positive

HorizonPredicted net PnL
20 days+1.81%
60 days+4.48%
252 days (1y)+19.70%

FY2012 short

1 signal fired · match: singles_avg

fcf_turn_negative

HorizonPredicted net PnL
20 days+1.36%
60 days-1.61%
252 days (1y)-16.85%

Methodology: /methodology · Live JSON: /api/company/73290/financials